Bob Long

About Bob Long

Bob Long is an experienced business executive and entrepreneur with a special knack for strategic planning, accountability and results-driven success. As Co-Founder and CEO of MicroVascular Health Solutions (MVHS) and CEO of GlycoCheck, Bob oversees commercial operations and is committed to developing an organization that explores medical device companies and nutritional therapies focused on lowering healthcare costs. MVHS develops technology and disseminates information to increase awareness and promote the proper care of the endothelial glycocalyx, the micro-thin lining of healthy blood vessels that serves as the first line of defense against plaque, fats and cholesterol, which is integral in maintaining cardiovascular health. Bob and Co-Founder Hans Vink have built a talented team in MicroVascular Health Solutions, which is dedicated to educating research institutions, clinicians and consumers. MVHS creates medical devices and nutritional supplements that monitor and support the health and well being of the microvascular system. During his spare time, Bob loves to spend time with his wife of 39 years and their four kids and 15 grandkids. He also volunteers for his church and enjoys fishing, boating, motorsports, reading, travel, golf and all types of music. One of Bob\'s greatest talents both inside the boardroom and out in the world is his ability to motivate team members to success, which is evident in the results he has delivered to his companies and their stakeholders.

Experience

1. CEO President Founder

   Microvascular Health Solutions Glycocheck

   May 2014 — Present · Alpine, UT, US

   Founded in 2014, MicroVascular Health Solutions is dedicated to the well-being of the human microvascular system by supporting the health of the endothelial glycocalyx – the micro-thin lining of healthy blood vessels that serves as a defense against oxidants, fats and cholesterol. MicroVascular Health Solutions is the worldwide distributor of GlycoCheck, a clinically validated Class 1 medical device (digital microscopic camera) with software that enables monitoring and evaluation of the overall strength and dimension of the glycocalyx. For more information, visit MicroVascular.com. MicroVascular Health Solutions is also a major investor, partner and sole U.S. distributor of GlycoCheck Microvascular Health Monitor (MHM), a complete imaging solution for screening patients’ perfused boundary region (PBR) by measuring and monitoring changes in the PBR accurately and in real time. These changes correlate with the changes in the glycocalyx layer. The measurement is performed non-invasively with a digital microscope camera that is placed under the patient\'s tongue. MIcroVascular Health Solutions is the owner and creator of Endocalyx a proprietary, patent pending dietary supplement that has been clinically shown to maintain a healthy glycocalyx.* The glycocalyx is the micro-thin gel layer that lines the inside of all blood vessels throughout the body and all organs. Endocalyx provides the building blocks needed for a strong and vital glycocalyx, strengthening this micro-thin shield that protects the heart, arteries, microcirculation and veins.* It helps keep blood vessels slick smooth and protected inside, from the largest arteries and veins to the tiniest capillaries.* This keeps blood flowing freely while optimizing circulation throughout the entire body** These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnosis, treat, cure or prevent any disease.

Education

• Brigham Young University

  Business Administration and Management, General

• Brigham Young University

  Business Management